Phase 1 Single Dose, Double-blind, Dose-escalation, Safety, Tolerability and Pharmacokinetic Study of NCTX (PEGylated Liposomal Iodixanol Injection) in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 14 Oct 2014
At a glance
- Drugs Iodixanol pegol (Primary)
- Indications Cancer; Cardiovascular disorders
- Focus Diagnostic use
- Sponsors Marval Pharma
- 09 Oct 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Mar 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrial.gov record.
- 25 Feb 2014 New trial record